Sintx Technologies (NASDAQ:SINT) shot up 7.5% on Wednesday . The stock traded as high as $1.61 and last traded at $1.58, 161,602 shares changed hands during trading. A decline of 58% from the average session volume of 383,291 shares. The stock had previously closed at $1.47.
Several research firms have weighed in on SINT. Maxim Group restated a “hold” rating on shares of Sintx Technologies in a report on Tuesday, September 24th. Ascendiant Capital Markets assumed coverage on Sintx Technologies in a research note on Wednesday, September 11th. They issued a “buy” rating and a $3.00 price objective for the company.
The firm’s 50 day moving average is $2.00. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.37 and a quick ratio of 2.33.
Sintx Technologies (NASDAQ:SINT) last posted its quarterly earnings data on Monday, November 18th. The company reported ($0.84) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.21) by $0.37. The business had revenue of $0.17 million during the quarter. Sintx Technologies had a negative return on equity of 70.34% and a negative net margin of 657.71%.
Sintx Technologies Company Profile (NASDAQ:SINT)
Sintx Technologies, Inc, a biomaterial company, researches, develops, manufactures, and commercializes a range of medical implant products manufactured with silicon nitride in the United States, Europe, and South America. The company offers ceramic based biomaterial solutions in various medical and industrial applications.
Further Reading: Options Trading – What is a Straddle?
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.